✦ LIBER ✦

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

✍ Scribed by David Cunningham; Seppo Pyrhönen; Roger D James; Cornelis JA Punt; Tamas F Hickish; Reino Heikkila; Tom B Johannesen; Hans Starkhammar; Clare A Topham; Lucile Awad; Christian Jacques; Patrice Herait

Book ID: 117311216
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 169 KB
Volume: 352
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(98)02309-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised trial of irinotecan plus supp

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

✍ David Cunningham; Seppo Pyrhönen; Roger D James; Cornelis JA Punt; Tamas F Hicki 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 169 KB

Background In phase II studies, irinotecan is active in metastatic colorectal cancer, but the overall benefit has not been assessed in a randomised clinical trial. Methods Patients with proven metastatic colorectal cancer, which had progressed within 6 months of treatment with fluorouracil, were ra

Randomised comparison of fluorouracil, e

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

✍ Pyrhönen, S; Kuitunen, T; Nyandoto, P; Kouri, M 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 1018 KB

Randomised trial of irinotecan versus fl

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

✍ Philippe Rougier; Eric Van Cutsem; Emilio Bajetta; Norbert Niederle; Kurt Possin 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 167 KB

Zalutumumab plus best supportive care ve

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

✍ Jean-Pascal Machiels; Somasundaram Subramanian; Agnes Ruzsa; Gabor Repassy; Igor 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 315 KB

Maintenance therapy with pemetrexed plus

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

✍ Luis Paz-Ares; Filippo de Marinis; Mircea Dediu; Michael Thomas; Jean-Louis Pujo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 244 KB